期刊文献+

3%高渗盐水联合利巴韦林雾化治疗上呼吸道感染的疗效观察 被引量:4

Effect of 3% hypertonic saline combined with ribavirin atomization inhalation in treatment of upper respiratory tract infection
下载PDF
导出
摘要 目的观察3%高渗盐水联合利巴韦林超声雾化吸入治疗上呼吸道感染的疗效。方法将163例上呼吸道感染患者随机分为三组(A组57例、B组53例和C组53例)。在常规治疗的基础上,A组加用0.9%生理盐水10 ml+庆大霉素8万U+地塞米松5 mg超声雾化吸入;B组加用0.9%生理盐水10 ml+利巴韦林0.1 g+地塞米松5 mg超声雾化吸入;C组加用3%高渗盐水10 ml+利巴韦林0.1 g+地塞米松5 mg超声雾化吸入,2次/d,疗程4 d。比较三组疗效和咽痛、咽痒、声嘶及咳嗽缓解时间及不良反应。结果 C组在咽痛、咽痒、声嘶及咳嗽缓解时间上优于A组;在咽痒方面优于B组。A组有1例用庆大霉素雾化后出现哮喘等过敏反应,另两组未出现不良反应。结论 3%高渗盐水联合利巴韦林超声雾化吸入治疗上呼吸道感染能改善症状,缩短病程,无不良反应。 Objective To observe the effects of 3% hypertonie saline combined with ribavirin atomization inhalation in the treatment of upper respiratory tract infection. Methods 163 patients with upper respiratory tract in- fection were randomly divided into three groups, with 57 cases in group A, 53 cases in group B and 53 cases in group C. On basis of the conventional treatment in the three groups, Group A was treated with ultrasonic atomization inhalation of 0. 9% saline 10 ml + Gentamicin 80 000 units + 5 mg dexamethasone ; Group B was treated with ultrasonic atomization inhalation of 3% hypertonic saline 10 ml + ribavirin 0. 1 g + 5 mg dexamethasone; Group C was with 3% hypertonic saline 10 ml + ribavirin 0. 1 g + 5 mg dexamethasone ultrasonic atomizing inhalation on the basis of the conventional treatment, all of the three groups were treated two times a day, four days for a course of treatment. The efficacy and sore throat, itchy throat, hoarseness and cough relief time and adverse reaction were compared among the three groups. Results Sore throat, itchy throat, hoarseness and cough relief were improved better in group C than those in group A. Pharyngeal itching relieving time was shorter in group C than that in group B. No adverse reactions occurred except that one case in group A experienced asthmatic symptoms after using gentamiein aerosol because of allergic reaction. Conclusion 3% hypertonic saline combined with ribavirin ultrasound atomization inhalation is ef- fective and safe in the treatment of upper respiratory tract infection. It can improve clinical symptoms and shorten the course of disease.
出处 《中国临床新医学》 2015年第11期1047-1049,共3页 CHINESE JOURNAL OF NEW CLINICAL MEDICINE
基金 广西壮族自治区人民医院医疗新技术项目
关键词 3%高渗盐水 利巴韦林 雾化吸入 上呼吸道感染 3% hypertonic saline Ribavirin Atomization inhalation Upper respiratory tract infection
  • 相关文献

参考文献3

二级参考文献38

  • 1沈晓明,王卫平.儿科学[M].第7版.北京:人民卫生出版社,2009:94. 被引量:39
  • 2Klassen TP. Recent advances in the treatment of bronchiolitis and laryngitis. Pediatr Clin North Am, 1997,44 ( 1 ) : 249-261. 被引量:1
  • 3Meissner HC. Selected populations at increased risk from respiratory syncytial virus infection. Pediatr Infect Dis J,2003, 22(S2) :40-44. 被引量:1
  • 4Panitch HB, Callahan CW, Schidlow DV. Bronchiolitis in children. Chn Chest Med, 1993, 14(4) :715-731. 被引量:1
  • 5Wohl ME, Chernick VC. Treatment of acute bronchiolitis. N Engl J Med, 2003, 349( 1 ) :82-83. 被引量:1
  • 6Perrotta C, Ortiz Z, Roque M, et al. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev, 2007, (1): CD004873. 被引量:1
  • 7Gadomski AM, Brower M . Bronchodilators for bronchiolitis. Cochrane Database Syst Rev ,2010, (12) : CD001266. 被引量:1
  • 8Fernandes RM, Bialy LM,Vandermeer B, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev, 2010, (10) :CDO04878. 被引量:1
  • 9Flores G, Horwitz RI Efficacy of beta2-agonists in bronchiolitis : a reappraisal and recta-analysis, Pediatrics, 1997, 100(2) :233-239. 被引量:1
  • 10Kellett F, Redfern J, Niven RM. Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis. Respir Med, 2005,99 ( 1 ) : 27-31. 被引量:1

共引文献107

同被引文献41

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部